Agency Reviews Safety of Foot Gel for Diabetics
The FDA issued a communication on March 27 about its ongoing safety review of Regranex (becaplermin gel, Ortho-McNeil), a topical medicine applied directly to the foot and leg ulcers of patients with diabetes.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.